Starmer’s China Visit Underscores Limits of a ’Pivot’ in Response to Trump
British Prime Minister Keir Starmer’s trip to China produced modest commercial wins - 30-day visa-free access for British visitors, lower whisky tariffs and a $15 billion AstraZeneca investment - but the visit also highlights the limitations facing Western governments that attempt to rebalance ties toward Beijing as a hedge against U.S. policy unde…